Induction of apoptosis in cancer

New therapeutic opportunities

Hanfei Ding, David E. Fisher

Research output: Contribution to journalReview article

42 Citations (Scopus)

Abstract

Autonomous cell proliferation is one of the hallmarks of cancer cells, driven by activated growth-promoting oncogenes. However, deregulated activation of these oncogenes also triggers apoptosis via multiple pathways. Among them, the ARF-p53 pathway appears to play a major role in mediating oncogene-induced apoptosis. Consequently, suppression of apoptosis by inactivation of p53 and other tumor suppressors is central to tumor development. These findings have broad implications in understanding cancer genetics and therapy. They help define the roles for oncogenes and tumor suppressor genes in tumorigenesis. Furthermore, the notion that cancer cells often carry specific defects in apoptotic pathways but are inherently sensitive to apoptosis as a result of deregulated proliferation, offers numerous opportunities for manipulating apoptosis in directions of clinical application.

Original languageEnglish (US)
Pages (from-to)451-469
Number of pages19
JournalAnnals of Medicine
Volume34
Issue number6
DOIs
StatePublished - Dec 1 2002
Externally publishedYes

Fingerprint

Oncogenes
Apoptosis
Neoplasms
Therapeutics
Tumor Suppressor Genes
Genetic Therapy
Carcinogenesis
Cell Proliferation
Growth

Keywords

  • Apoptosis
  • Cancer therapy
  • Oncogene
  • Tumor suppressor gene
  • Tumorigenesis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Induction of apoptosis in cancer : New therapeutic opportunities. / Ding, Hanfei; Fisher, David E.

In: Annals of Medicine, Vol. 34, No. 6, 01.12.2002, p. 451-469.

Research output: Contribution to journalReview article

Ding, Hanfei ; Fisher, David E. / Induction of apoptosis in cancer : New therapeutic opportunities. In: Annals of Medicine. 2002 ; Vol. 34, No. 6. pp. 451-469.
@article{3ccc8d2a306b41fd9fe9e60ac53dcb26,
title = "Induction of apoptosis in cancer: New therapeutic opportunities",
abstract = "Autonomous cell proliferation is one of the hallmarks of cancer cells, driven by activated growth-promoting oncogenes. However, deregulated activation of these oncogenes also triggers apoptosis via multiple pathways. Among them, the ARF-p53 pathway appears to play a major role in mediating oncogene-induced apoptosis. Consequently, suppression of apoptosis by inactivation of p53 and other tumor suppressors is central to tumor development. These findings have broad implications in understanding cancer genetics and therapy. They help define the roles for oncogenes and tumor suppressor genes in tumorigenesis. Furthermore, the notion that cancer cells often carry specific defects in apoptotic pathways but are inherently sensitive to apoptosis as a result of deregulated proliferation, offers numerous opportunities for manipulating apoptosis in directions of clinical application.",
keywords = "Apoptosis, Cancer therapy, Oncogene, Tumor suppressor gene, Tumorigenesis",
author = "Hanfei Ding and Fisher, {David E.}",
year = "2002",
month = "12",
day = "1",
doi = "10.1080/078538902321012405",
language = "English (US)",
volume = "34",
pages = "451--469",
journal = "Annals of Medicine",
issn = "0785-3890",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Induction of apoptosis in cancer

T2 - New therapeutic opportunities

AU - Ding, Hanfei

AU - Fisher, David E.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Autonomous cell proliferation is one of the hallmarks of cancer cells, driven by activated growth-promoting oncogenes. However, deregulated activation of these oncogenes also triggers apoptosis via multiple pathways. Among them, the ARF-p53 pathway appears to play a major role in mediating oncogene-induced apoptosis. Consequently, suppression of apoptosis by inactivation of p53 and other tumor suppressors is central to tumor development. These findings have broad implications in understanding cancer genetics and therapy. They help define the roles for oncogenes and tumor suppressor genes in tumorigenesis. Furthermore, the notion that cancer cells often carry specific defects in apoptotic pathways but are inherently sensitive to apoptosis as a result of deregulated proliferation, offers numerous opportunities for manipulating apoptosis in directions of clinical application.

AB - Autonomous cell proliferation is one of the hallmarks of cancer cells, driven by activated growth-promoting oncogenes. However, deregulated activation of these oncogenes also triggers apoptosis via multiple pathways. Among them, the ARF-p53 pathway appears to play a major role in mediating oncogene-induced apoptosis. Consequently, suppression of apoptosis by inactivation of p53 and other tumor suppressors is central to tumor development. These findings have broad implications in understanding cancer genetics and therapy. They help define the roles for oncogenes and tumor suppressor genes in tumorigenesis. Furthermore, the notion that cancer cells often carry specific defects in apoptotic pathways but are inherently sensitive to apoptosis as a result of deregulated proliferation, offers numerous opportunities for manipulating apoptosis in directions of clinical application.

KW - Apoptosis

KW - Cancer therapy

KW - Oncogene

KW - Tumor suppressor gene

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=0036919717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036919717&partnerID=8YFLogxK

U2 - 10.1080/078538902321012405

DO - 10.1080/078538902321012405

M3 - Review article

VL - 34

SP - 451

EP - 469

JO - Annals of Medicine

JF - Annals of Medicine

SN - 0785-3890

IS - 6

ER -